We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
266 hedge funds and large institutions have $4.57B invested in Intra-Cellular Therapies Inc. in 2022 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 90 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
142% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 19
35% more call options, than puts
Call options by funds: $33.5M | Put options by funds: $24.9M
10% more funds holding
Funds holding: 241 → 266 (+25)
3% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 90
6% less capital invested
Capital invested by funds: $4.88B → $4.57B (-$307M)
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
Holders
266
Holders Change
+25
Holders Change %
+10.37%
% of All Funds
4.48%
Holding in Top 10
11
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-15.38%
% of All Funds
0.19%
New
46
Increased
93
Reduced
90
Closed
19
Calls
$33.5M
Puts
$24.9M
Net Calls
+$8.6M
Net Calls Change
-$8.72M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$114M |
| 2 |
Holocene Advisors
New York
|
+$51.3M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$44M |
| 4 |
BlackRock
New York
|
+$32.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.8M |
